HIF-1α–Nrf2 crosstalk in myocardial ischemia–reperfusion injury: a potential preconditioning-responsive protective network
- 1Acupuncture and Massage College, Graduate School, Heilongjiang University of Chinese Medicine , ,
- 2Liaoning University of Chinese Medicine , ,
Abstract
Myocardial ischemia-reperfusion injury (MIRI) is a dynamic pathological process in which metabolic and mitochondrial disturbances during ischemia predispose the myocardium to oxidative damage upon reperfusion. This temporal coupling poses a fundamental limitation to single-pathway cardioprotection, as interventions directed at one stage of injury may fail to adequately address the evolving pathophysiological cascade. Hypoxia-inducible factor-1α (HIF-1α) and nuclear factor erythroid 2-related factor 2 (Nrf2), key regulators of hypoxic adaptation and cellular redox homeostasis, respectively, may constitute an interconnected protective network that spans the ischemia-reperfusion transition. HIF-1α promotes metabolic reprogramming and mitochondrial adaptation during ischemia, thereby reducing oxidative susceptibility, whereas Nrf2 enhances glutathione metabolism, peroxide detoxification, and resistance to lipid peroxidation during reperfusion. Emerging evidence further suggests the possibility of reciprocal crosstalk between these pathways, with HIF-1α reported to facilitate Nrf2 activation and Nrf2 to support HIF-1α transcriptional availability and protein stability. This coupling may enable preconditioning to establish metabolic and mitochondrial adaptation before ischemia while simultaneously building an antioxidant defense reserve for reperfusion, while sustained metabolic adaptation during early reperfusion provides transitional support for the recovery of oxidative metabolism, thereby limiting secondary oxidative injury. Compared with isolated pathway activation, coordinated HIF-1α-Nrf2 regulation may therefore provide broader and more temporally integrated cardioprotection by simultaneously reducing oxidative susceptibility and enhancing resistance to reperfusion stress. Pharmacological and non-pharmacological preconditioning studies further support the therapeutic potential of this network-based strategy, highlighting HIF-1α-Nrf2 crosstalk as a promising framework for optimizing cardioprotection in MIRI.
Related
- Electroacupuncture preconditioning and mitochondria-associated outcomes in animal models of myocardial ischemia-reperfusion injury: a systematic review and meta-analysis
- Protective effects and underlying mechanisms of naringenin in myocardial ischemia/reperfusion injury: a systematic review and preclinical meta-analysis
- A review of protective effects of Withania somnifera and its bioactive component withaferin A in organ ischemia-reperfusion injury
- Statement of Retraction: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.
- Myocardial Ischemia-Reperfusion Injury: Molecular Mechanisms and Innovative Therapeutic Strategies
BibTeX
@article{guo2026hif1αnrf2,
title = {{HIF-1α–Nrf2 crosstalk in myocardial ischemia–reperfusion injury: a potential preconditioning-responsive protective network}},
author = {Xiaoqiang Guo and Chaojie Wang and Shuyan Zhang and Mengqi Li and Chen Chen},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1976117},
url = {https://europepmc.org/article/PMC/PMC13717146},
note = {CC BY},
}
RIS
TY - JOUR
TI - HIF-1α–Nrf2 crosstalk in myocardial ischemia–reperfusion injury: a potential preconditioning-responsive protective network
AU - Xiaoqiang Guo
AU - Chaojie Wang
AU - Shuyan Zhang
AU - Mengqi Li
AU - Chen Chen
PY - 2026
DA - 2026/10/15
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1976117
UR - https://europepmc.org/article/PMC/PMC13717146
AB - Myocardial ischemia-reperfusion injury (MIRI) is a dynamic pathological process in which metabolic and mitochondrial disturbances during ischemia predispose the myocardium to oxidative damage upon reperfusion. This temporal coupling poses a fundamental limitation to single-pathway cardioprotection, as interventions directed at one stage of injury may fail to adequately address the evolving pathophysiological cascade. Hypoxia-inducible factor-1α (HIF-1α) and nuclear factor erythroid 2-related factor 2 (Nrf2), key regulators of hypoxic adaptation and cellular redox homeostasis, respectively, may constitute an interconnected protective network that spans the ischemia-reperfusion transition. HIF-1α promotes metabolic reprogramming and mitochondrial adaptation during ischemia, thereby reducing oxidative susceptibility, whereas Nrf2 enhances glutathione metabolism, peroxide detoxification, and resistance to lipid peroxidation during reperfusion. Emerging evidence further suggests the possibility of reciprocal crosstalk between these pathways, with HIF-1α reported to facilitate Nrf2 activation and Nrf2 to support HIF-1α transcriptional availability and protein stability. This coupling may enable preconditioning to establish metabolic and mitochondrial adaptation before ischemia while simultaneously building an antioxidant defense reserve for reperfusion, while sustained metabolic adaptation during early reperfusion provides transitional support for the recovery of oxidative metabolism, thereby limiting secondary oxidative injury. Compared with isolated pathway activation, coordinated HIF-1α-Nrf2 regulation may therefore provide broader and more temporally integrated cardioprotection by simultaneously reducing oxidative susceptibility and enhancing resistance to reperfusion stress. Pharmacological and non-pharmacological preconditioning studies further support the therapeutic potential of this network-based strategy, highlighting HIF-1α-Nrf2 crosstalk as a promising framework for optimizing cardioprotection in MIRI.
SN - 2296-858X
ER -